Adhesion molecules as a prognostic marker of liver cirrhosis (Q46374828)

21 December 2017

title

Adhesion molecules as a prognostic marker of liver cirrhosis (English)

1 reference

21 December 2017

0 references

Girón-González JA

1

1 reference

21 December 2017

Martínez-Sierra C

2

1 reference

21 December 2017

Rodriguez-Ramos C

3

1 reference

21 December 2017

Rendón P

4

1 reference

21 December 2017

Macías MA

5

1 reference

21 December 2017

Fernández-Gutiérrez C

6

1 reference

21 December 2017

Díaz F

7

1 reference

21 December 2017

Martín-Herrera L

8

1 reference

21 December 2017

publication date

1 February 2005

1 reference

21 December 2017

Scandinavian Journal of Gastroenterology

published in

1 reference

21 December 2017

volume

40

1 reference

21 December 2017

issue

2

1 reference

21 December 2017

page(s)

217-224

1 reference

21 December 2017

Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365520510011470

Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510011470

Implication of inflammation-related cytokines in the natural history of liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510011470

Dilutional hyponatremia in patients with cirrhosis and ascites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510011470

Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510011470

Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510011470

The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510011470

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510011470

Tumor necrosis factor soluble receptor p55 and lipid peroxidation in patients with acute alcoholic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510011470

Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510011470

Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510011470

Proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510011470

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510011470

Bacterial infections in liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510011470

Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510011470

10.1080/00365520510011470

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017